Medibio: Successfully completes pilot program for Compass Group
- Medibio (MEB) has successfully completed a pilot program for British food and catering company Compass
- Medibio’s novel mental health and wellbeing program, ilumen, aims to aid in the early detection and screening of mental health conditions
- Medibio presented the ilumen pilot results to Compass management, providing valuable insights into employee wellbeing
- The program was able to identify lost productivity hours, providing Compass with a dollar value of potential losses
- The two companies are now in discussions regarding the ongoing implementation of ilumen
- Medibio is still trading at its opening price of 0.8 cents a share
